1. Technical Field
This present disclosure relates to a cannula useful for penetrating membranes or septums as commonly used in medication vials, intravenous bags, access ports and the like.
2. Description of the Related Art
Many standard containers for pharmaceuticals, medicaments and other substances are air and moisture-tight containers (e.g., vials) having elastomeric stoppers. The container contents are typically accessed by piercing the stopper with a cannulated needle apparatus such as a typical hypodermic needle and syringe. In many applications, the container contents are repeatedly accessed. For example, many injectable pharmaceuticals are packaged in multidose vials requiring a vial access for the withdrawal of each unit dose. Also, many pharmaceuticals are lypholysed in sterile vials for prolonged stability. Such packaging also requires multiple vial entries to reconstitute the contents and withdrawal of the reconstituted contents.
Typically, the elastomeric stoppers are pierced using a sharp metal cannulated needle; usually a needle suitable for intravenous injection. One problem that arises with this type of vial access is coring of the elastomeric stopper. Coring occurs as the vial access needle is urged through the stopper and the needle punches or cuts a small particle of rubber from the stopper. This stopper fragment either drops into the vial or becomes lodged in the cannula and possibly withdrawn into the syringe. In either case, the sterility of the container contents is compromised and, in the latter case, injection of particulate matter into the patient may occur.
The prior art discloses various vial access needles for aspiration of medication including vial access needles providing conically shaped forward tips and fluid dispensing side ports. See, for example, the MONOJECT® Filter Aspiration Needle (1973) manufactured by Sherwood Medical Industries Inc. and U.S. Pat. No. 4,058,121 to Choksi et al., which disclose vial access needles for aspiration of medication.
Therefore, it would be desirable to overcome the disadvantages and drawbacks of the prior art with a vial access cannula that employs structure that minimizes or eliminates coring of elastomeric stoppers. It would also be desirable if the vial access cannula is easily and efficiently manufactured.
Accordingly, a cannula useful for penetrating membranes or septums as commonly used in medication vials, intravenous bags, access ports and the like is provided having a blunt tip vial access cannula that employs structure for penetrating vials and the like for prevent coring of elastomeric stoppers to prevent particulates from the stopper from invading the pharmaceutical or medicament to overcome the related disadvantages and drawbacks of the prior art. Desirably, the blunt tip vial access cannula includes a solid tip member structure that prevents coring of septums as commonly used in medication vials, intravenous bags, access ports and the like.
One particular embodiment of the present disclosure provides a non-coring cannula for use as a vial access needle. The cannula described herein has sufficient structural strength that it may be made from a thermoplastic resin instead of metal, thus reducing the likelihood and severity of operator injury by an accidental needle stick. The vial access cannula of the present disclosure includes (i) a needle hub suitable for receiving a hypodermic syringe or an IV set, (ii) a cannula portion having a centrally disposed lumen, wherein the centrally disposed lumen terminates in one or more distal openings and is in fluid communication with the needle hub, and (iii) a solid tip member distal to the one or more distal openings, wherein the solid tip member has a blade with a cutting edge. In preferred embodiments, the centrally disposed lumen terminates in two distal openings and the distal openings are oriented such that the fluid flow is transverse to the axis of the centrally disposed lumen.
Preferably, the blade is disposed at an angle α of about 5-45° from the vertical plane perpendicular to the longitudinal axis of the cannula, and most preferably, the blade is disposed at an angle of about 10-20°.
In another illustrative embodiment, the solid tip member of the vial access cannula has one or more bevels such that the vertical length of the cutting edge is about 50-95% of the diameter of the cannula portion. The bevels that cause the length reduction of the cutting blade are disposed medially at an angle of about 5-25°, and most preferably, about 8-15°.
In another embodiment, the vial access cannula has lateral facets spanning the distal end of the cannula portion, from a point proximal to the lateral openings, and the proximal end of the solid tip member. In preferred embodiments, the distal boundary of the lateral facet is the proximal edge of the bevel that forms the cutting edge of the blade. In another embodiment, there is an additional laterally disposed bevel between the distal boundary of the facet and the bevel that forms the cutting edge. In one embodiment, the laterally disposed facets contain a medial groove which is disposed parallel to the longitudinal axis of the vial access cannula. Typically, the medial grooves have substantially the same width as the distal openings of the centrally disposed cannula and run distally from the distal openings. On the distal end, the medial grooves terminate prior to the proximal boundary of the bevel that forms the cutting edge.
In particularly useful embodiments, the interior wall of the needle hub is tapered which facilitates a Luer slip-type of connection. In other embodiments, the needle hub contains a female portion of a Luer lock (i.e., the Luer wings). Optionally, the needle hub, the flange, or the proximal end of the centrally disposed cannula may contain a filter. Useful filters include membrane filters (e.g., PVDF or methylcellulose), or microporous metal (e.g., stainless steel) filters.
The foregoing and other features and advantages of the present disclosure will be more fully understood from the following detailed description of the exemplary embodiments, taken in conjunction with the accompanying drawings in which:
The exemplary embodiments of the blunt tip vial access needle disclosed herein are discussed in terms of cannulated needle devices for infusion of intravenous fluids, medication infusion and fluid collection, and more particularly, in terms of manually accessing vials of pharmaceuticals and the like housed in containers that employ septum structures that require access such as medication vials, intravenous bags, access ports and the like. It is contemplated that the cannula may be shielded during storage, transport, fluid infusion and/or collection and subsequent thereto.
In the discussion that follows, the term “proximal” refers to a portion of a structure that is closer to a clinician, and the term “distal” refers to a portion that is further from the clinician. As used herein, the term “subject” refers to a patient that receives infusions or has blood and/or fluid collected therefrom using the safety apparatus. According to the present disclosure, the term “clinician” refers to an individual administering an infusion, performing fluid collection, installing or removing a needle cannula from a safety apparatus and may include support personnel.
Additionally, the term “cutting edge” refers to the union of one or more bevels and is located at the distal end of the cannula. The term “slanted blade” refers to a cutting edge, together with one or more bevels that form the cutting edge, in which the angle of the cutting edge is less than perpendicular to the longitudinal axis of the cannula to which it is attached.
The following discussion includes a description of the blunt tip vial access cannula, in accordance with the present disclosure. Reference will now be made in detail to the exemplary embodiments of the disclosure, which are illustrated in the accompanying figures.
Turning now to the figures, wherein like components are designated by like reference numerals throughout the several views. Referring to
The needle hub 12 is designed to receive a syringe or an IV set (not shown) and, in preferred embodiments, comprises the female portion of a Luer Lock 11 (i.e., has “ears” for mating with the threaded male Luer connector). Preferably, the interior wall of the needle hub 12 is tapered distally for providing a frictional fit with received syringes or IV sets (i.e., capable of functioning as a Luer slip connection). Other configurations of the needle hub 12 are possible and depend upon each particular receiving syringe or device with which the cannula 10 of the present disclosure will be used.
The centrally disposed lumen 18 extends through the flange 13 and is in fluid communication with the needle hub 12 at the proximal end 14. The centrally disposed lumen 18 terminates in one or more distal openings 20. In preferred embodiments, distal openings 20 are laterally disposed to the central longitudinal X-axis of the cannula 10. In other preferred embodiments, the lumen 18 terminates with two opposing distal openings 20, which are oriented at 90° to the cutting edge of cutting edge 32.
Optionally, the needle hub 12 may include a filter within the centrally disposed lumen 18 or the interior portions of flange 13 or hub 12. Particularly useful filters include, for example, a microporous stainless steel filter. Suitable filters include, for example, 0.22 μm and 0.45 μm membrane filters, and 5 μm random path membrane filters. The choice of needle hub filter is left to the practitioner based on each specific application. Generally, the manufacture and use of needle hub filters is well known in the art.
During operation, the flange portion 13 is designed to engage a top portion of the vial or elastomeric stopper into which the cannula 10 is to be inserted such that the flange 13 limits the depth of cannula 10 penetration through the elastomeric stopper. There is no specific requirement for the shape of the flange 13, but in preferred embodiments, it contains one or more wing or stop members 15 symmetrically distributed around the flange 13 circumference and extending radially outwards. Preferably, neither the flange 13 nor its wings 15 extend outward beyond the width of the needle hub 12.
The solid tip member 26 contains a slanted blade 30 containing a cutting edge 32 which is formed at the junction of the bevels 22. It is contemplated within the present disclosure that cutting edge 32 is not perpendicular (i.e., slanted) in relation to longitudinal X-axis of cannula 10. The slanted blade 30, including the cutting edge 30 and the bevels 22, facilitate penetration of the elastomeric stoppers and other vial closure devices. The solid tip member 26 further contains medial grooves 28 extending substantially from the distal openings 20 running in a distal direction parallel to the centrally disposed lumen 18, but terminating prior to the proximal edge of the bevels 22. The medial grooves 28 facilitate flow when fluid is drawn into the syringe (not shown) through the cannula 10.
The presence of medial grooves 28 assist manufacture of the device in the mold by diverting the stream of ejected fluid within the angle, most preferably about 45°, from the tip.
Cannula 10 includes an additional facet 38 bridging the distal end of the cannula portion 16 and the solid tip member 26. The facets 38 are typically symmetrical on each of the lateral sides of the cannula 10 and are oriented parallel to the cutting edge 32. The purpose of the facet 38 is to facilitate penetration of the solid tip member 26 and the cannula portion 16 of the cannula 10 through an elastomeric vial stopper. Cannulae without the facets 38 generally require the use of more force and are more prone to tear the vial stopper.
With reference to
The cutting edge 32 of the slanted blade 30 is disposed at an angle α of preferably about 5-45°, more preferably 10-30° and most preferably about 10-20°, to vertical axis (Z-Z) shown as perpendicular to the longitudinal X-axis of the cannula 10 (
Turning now to
With reference to
With reference now to
As discussed above, in preferred embodiments, the solid tip member 26 has at least one bevel 36 on the first side 50 and at least one bevel 37 on the second side 60. Most preferably, each angle γ and γ′ of the bevel is about 8-15°. In this preferred embodiment, which has both bevels 36 and 37 at about an 11° angle γ and γ′, the vertical length of the cutting edge 32 is about 0.058 cm which represents a reduction of about 0.030 cm compared to the diameter G of the cannula portion 16. The 0.030 cm reduction in vertical length I is comprised of about a 0.015 cm reduction on both the first side 50 and the second side 60.
As discussed above, preferably, the needle hub 12 is mating with the male portion of a threaded Luer connector and/or functioning as a Luer slip connector. Suitable dimensions for these types of connectors are well known in the art. For example, the depth C of the syringe receiving portion of the needle hub 12 is about 0.305 cm and is flared over about the proximal 0.25 cm of depth J. In a suitable flared configuration, the needle hub 12 has a luminal diameter K of about 0.155 cm toward the distal end and a luminal diameter L of about 0.210 cm toward the proximal opening. The exterior diameter of the needle hub, excluding the Luer ears 11, is about 0.234 cm. In another preferred embodiment, the inner corner of the proximal opening of the needle hub 12 is beveled to an angle θ2, which facilitates entry of the syringe end into the needle hub 12. Suitably, θ2 may be about 30-55°, but preferably is about 45°.
With reference to
With reference to
Although the foregoing present disclosure has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this present disclosure that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
2512568 | Saffir | Jun 1950 | A |
2541272 | Murphy | Feb 1951 | A |
2590895 | Scarpellino | Apr 1952 | A |
2746455 | Abel | May 1956 | A |
2752919 | Gabriel | Jul 1956 | A |
2954768 | Hamilton | Oct 1960 | A |
2989053 | Hamilton | Jun 1961 | A |
3076457 | Copen | Feb 1963 | A |
3119391 | Harrison | Jan 1964 | A |
3662754 | Halloran | May 1972 | A |
3776239 | Cooley | Dec 1973 | A |
3831814 | Butler | Aug 1974 | A |
4058121 | Choksi et al. | Nov 1977 | A |
4387879 | Tauschinski | Jun 1983 | A |
4505709 | Froning et al. | Mar 1985 | A |
4675020 | McPhee | Jun 1987 | A |
4710180 | Johnson | Dec 1987 | A |
4723955 | Vaillancourt | Feb 1988 | A |
4743243 | Vaillancourt | May 1988 | A |
4834152 | Howson et al. | May 1989 | A |
4838877 | Massau | Jun 1989 | A |
4842591 | Luther | Jun 1989 | A |
4990140 | Black | Feb 1991 | A |
5059172 | Sutherland et al. | Oct 1991 | A |
5071413 | Utterberg | Dec 1991 | A |
5167642 | Fowles | Dec 1992 | A |
5188620 | Jepson et al. | Feb 1993 | A |
5203775 | Frank et al. | Apr 1993 | A |
5211638 | Dudar et al. | May 1993 | A |
5364387 | Sweeney | Nov 1994 | A |
5470327 | Helgren et al. | Nov 1995 | A |
5584819 | Kopfer | Dec 1996 | A |
5746733 | Capaccio et al. | May 1998 | A |
5755696 | Caizza | May 1998 | A |
RE35841 | Frank et al. | Jul 1998 | E |
5820621 | Yale et al. | Oct 1998 | A |
5832971 | Yale et al. | Nov 1998 | A |
5833674 | Turnbull et al. | Nov 1998 | A |
5887633 | Yale et al. | Mar 1999 | A |
5919182 | Avallone | Jul 1999 | A |
5928162 | Giurtino et al. | Jul 1999 | A |
5928215 | Caizza et al. | Jul 1999 | A |
5976115 | Parris et al. | Nov 1999 | A |
6206858 | Kempen et al. | Mar 2001 | B1 |
6358236 | DeFoggi et al. | Mar 2002 | B1 |
6394979 | Sharp et al. | May 2002 | B1 |
6447498 | Jepson et al. | Sep 2002 | B1 |
6585697 | Kempen et al. | Jul 2003 | B2 |
6610041 | Daubert et al. | Aug 2003 | B2 |
6616632 | Sharp et al. | Sep 2003 | B2 |
6635043 | Daubert et al. | Oct 2003 | B2 |
6637470 | Reihl et al. | Oct 2003 | B2 |
6715520 | Andréasson et al. | Apr 2004 | B2 |
6832994 | Niedospial, Jr. et al. | Dec 2004 | B2 |
6875205 | Leinsing | Apr 2005 | B2 |
6921395 | Carano et al. | Jul 2005 | B2 |
20020019622 | Daubert et al. | Feb 2002 | A1 |
20040024354 | Reynolds | Feb 2004 | A1 |
20040039365 | Aramata et al. | Feb 2004 | A1 |
Number | Date | Country |
---|---|---|
2 845 276 | Apr 2002 | FR |
Entry |
---|
Sherwood Medical Industries Inc., Monoject Product Data Filter Aspiration Needle, Aug. 1973, pp. 1-8. |
Sherwood Medical Industries, Monoject Filter Aspiration Needle, An Efficient Stainless Steel Filter in a Needle Hub, 4 pages. |
European Search Report (8 pages). |
Number | Date | Country | |
---|---|---|---|
20060200095 A1 | Sep 2006 | US |